aod9604 peptide weight loss evidence clinical trials AOD-9604 Research AOD9604 Peptide — 2mg, 5mg,

Reduces Fat Cell Size and Promotes Lipolysis Research indicates that NNMT inhibition leads to shrinkage of white adipose tissue and a shift toward fat oxidation , making the body more efficient at burning stored fat for energy

In obese mouse models: Animals treated with 5-Amino-1MQ lost significant fat mass compared to controls Effects were most pronounced in visceral adipose tissue the metabolically dangerous fat around organs No cardiovascular toxicity or significant off-target effects were observed at research doses Body weight decreased without appetite changes, suggesting the mechanism was purely metabolic Human data is limited this is still a research compound

(6) Michael D Jensen (2006) Potential role of new therapies in modifying cardiovascular risk in overweight patients with metabolic risk factors Obesity (Silver Spring MD), 2006 Jun, Volume 14, Supplement 3, Pages 143S-149S

3 convenient locations Over 20 years of experience Board certified physician directed program Lose 10-30 lbs

Animal studies done on mice have shown that they reduced their body mass by about 7% without any external changes in food intake